-Revenue in EUR (TTM) IndustryBiotechnology & DrugsLocation

-Net income in EUR

1965
Incorporated

146
Employees

Cipan Companhia Industrial Produtora de Antibioticos SA Rua da Estacao, 42, Apartado 60 Vala do Carregado PO Box 60 Castanheira do Ribatejo VILA FRANCA DE XIRA2601-906 Portugal PRT Phone+351 263856800Fax+351 263855020Websitehttp://www.cipan.pt CIPAN Companhia Industrial Produtora de Antibioticos SA (CIPAN) is a Portugal-based company active in the pharmaceutical sector. The Company specializes in the research, development, production and commercialization of active pharmaceutical ingredients (API). Its activities include API fermentation and organic synthesis. The Company's products can be broken down into three categories: Fermentation, including potassium clavulanate and demeclocycline hydrochloride; Chemical Synthesis, representing the core products of the Company, including minocycline hydrochloride and doxycycline hyclate; as well as Sterile Products, such as potassium clavulanate. CIPAN's chemical and downstream operations include ultrafiltration, nanofiltration, salt conversion and crystallization, among others. As of December 31, 2010 the Company was part of the AtralCipan Group.

PeerAnalysis
Peer analysis
View
Key Information
Company Revenue (TTM) Net income (TTM) Market cap Employees

Akers Biosciences, Inc. Angel Biotechnology Holdings Plc Ark Therapeutics Group plc B.M.P. Pharma Trading AG ChronTech Pharma AB CIPAN - Cia Ind Prom de Ant SA Creative Antibiotics Sweden AB DiaGenic ASA Euroimplant SA Fornix Biosciences NV Genovis AB Inno-Gene SA Pharco SA Wntresearch AB Yield Life Science publ AB

1.09m -8.77m 52.16k 0 -2.78k 19.62k 1.71k 157.00k 710.05k --234.29k 131.90k

-2.78m --5.90m 207.12k -2.28m --2.06m -5.20m -1.56m -448.00k -1.78m ---664.10k -68.03k

3.52m 2.31m 2.44m 2.73m 4.61m 3.91m 2.45m 4.03m 4.46m 2.82m 5.34m 2.70m 3.68m 5.28m 4.80m

4000 37 63 35 1 146 6 19 18 0 13 1 11 2 -32768

Management Effectiveness
Peer analysis
View

Management Effectiveness
Return on average assets (TTM) Return on average assets (5 yr average)

Company

Return on investment (TTM)

Return on investment (5 yr average)

Akers Biosciences, Inc. Angel Biotechnology Holdings Plc Ark Therapeutics Group plc B.M.P. Pharma Trading AG ChronTech Pharma AB CIPAN - Cia Ind Prom de Ant SA Creative Antibiotics Sweden AB DiaGenic ASA Euroimplant SA Fornix Biosciences NV Genovis AB Inno-Gene SA Pharco SA Wntresearch AB Yield Life Science publ AB

-48.7541 --29.7397 --196.0199 --74.7757 -68.0932 -21.1535 -4.5965 -60.8332 ---90.774 -3.6942

-44.2433 --33.4283 -5.0834 -375.2577 -5.7372 --76.0319 -10.77 -100.3244 ----8.421

-52.844 --38.5853 --1,094.444 --81.9546 -75.333 -25.5146 -5.3207 -69.1418 ---114.3272 -3.8196

-44.2433 --33.4283 -5.0834 -375.2577 -5.7372 --76.0319 -10.77 -100.3244 ----8.421

Profitability
Peer analysis
View
Profitability
Return on average assets (TTM) Return on average assets (5 yr average)

Company

Return on investment (TTM)

Return on investment (5 yr average)

Akers Biosciences, Inc. Angel Biotechnology Holdings Plc Ark Therapeutics Group plc B.M.P. Pharma Trading AG ChronTech Pharma AB CIPAN - Cia Ind Prom de Ant SA Creative Antibiotics Sweden AB DiaGenic ASA Euroimplant SA Fornix Biosciences NV Genovis AB

-48.7541 --29.7397 --196.0199 --74.7757 -68.0932 -21.1535 -4.5965 -60.8332

-44.2433 --33.4283 -5.0834 -375.2577 -5.7372 --76.0319 -10.77 -100.3244

-52.844 --38.5853 --1,094.444 --81.9546 -75.333 -25.5146 -5.3207 -69.1418

-44.2433 --33.4283 -5.0834 -375.2577 -5.7372 --76.0319 -10.77 -100.3244

Company

Return on average assets (TTM)

Return on average assets (5 yr average)

Return on investment (TTM)

Return on investment (5 yr average)

Inno-Gene SA Pharco SA Wntresearch AB Yield Life Science publ AB

---90.774 -3.6942

----8.421

---114.3272 -3.8196

----8.421

Growth Rates
Peer analysis
View
Grow th Rates
Net income (5 Yr growth rate) Capital expenditure (5 Yr growth rate) Dividend (5 yr growth rate)

Company

Revenue (Year-over-year change%)

Revenue (5 yr growth rate)

Net income (Year-over-year change%)

Akers Biosciences, Inc. Angel Biotechnology Holdings Plc Ark Therapeutics Group plc B.M.P. Pharma Trading AG ChronTech Pharma AB CIPAN - Cia Ind Prom de Ant SA Creative Antibiotics Sweden AB DiaGenic ASA Euroimplant SA Fornix Biosciences NV Genovis AB Inno-Gene SA Pharco SA Wntresearch AB Yield Life Science publ AB

-41.536 -841.74 -32.0875 -7.61 -183.11 -87.1476 139.45 -9.2698 -1,742.42 -82.63

11.84 -83.36 26.66 -1.24 -120.04 --54.3329 101.98 ----29.3011

-289.6465 -76.50 -66.3105 2.48 101.39 -16.90 -181.6286 53.10 -20.515 -90.24 -133.2211 59.49

------15.6935 ----------

-38.9093 --30.9316 ---36.4096 --34.8482 ---25.6713 -----

----------------